Am. J. Respir. Crit. Care Med.,
Volume 164, Number 6, September 2001, 1083-1089
Restoring Effects of Vitamin A on Surfactant Synthesis
in Nitrofen-induced Congenital Diaphragmatic Hernia
in Rats
BERNARD
THÉBAUD,
ANNE-MARIE
BARLIER-MUR,
BERNADETTE
CHAILLEY-HEU,
ALEXANDRA
HENRION-CAUDE,
DICK
TIBBOEL,
ANH-TUAN
DINH-XUAN,
and
JACQUES R.
BOURBON
Réanimation Néonatale-UPRES 2704, Hôpital Antoine Béclère, Université Paris-Sud, Assistance Publique-Hôpitaux de Paris, Clamart; Service de
Physiologie, Hôpital Cochin, Université René Descartes, Paris; INSERM, U3 19, Université Denis Diderot Paris-7, Paris, France; Pediatric Surgery,
Sophia Children's Hospital, Rotterdam, The Netherlands
Congenital diaphragmatic hernia (CDH) is a major cause of refractory respiratory failure in the newborn. Besides pulmonary hypoplasia, the pathophysiology of CDH also includes surfactant deficiency. Vitamin A (vit A) is important for various aspects of lung
development. We hypothesized that antenatal treatment with vit A
would stimulate lung surfactant synthesis in experimental CDH
induced in rats by maternal ingestion of the herbicide nitrofen (2,4-dichloro-phenyl-p-nitrophenyl-ether) on Day 12. Fetuses were assigned to six experimental groups: (1) controls from rats that received olive oil, the vehicle; (2) fetuses from rats that received olive
oil on Day 12 and vit A orally (15,000 IU) on Day 14; (3) nitrofen
(N)-exposed fetuses without diaphragmatic hernia (N/no DH); (4)
N/no DH from rats given vit A on Day 14; (5 ) nitrofen-exposed fetuses with DH (N/+DH); (6) N/+DH from rats given vit A on Day 14. Fetuses were delivered by C-section at Day 21. Lung DNA content was lowered in the nitrofen group as compared with the controls group, but increased by subsequent vit A treatment. Lung surfactant disaturated phosphatidylcholine was reduced in the N/+DH
group and restored to control level by vit A. The expression level
of surfactant proteins (SP) -A and -C was decreased in vit A-treated control rats and in nitrofen-exposed fetuses with or without DH. Vit A restored SP-A and -C mRNA expression to control levels in N/+DH. SP-B expression was lowered in N/no DH and increased
by vit A in this group. The proportion of type II cells assessed by
SP-B immunolabeling was lowered in N/+DH and restored by vit A treatment. We conclude that antenatal treatment with vit A restores lung maturation in nitrofen-induced hypoplastic lungs with
CDH. These findings point out vit A as a potential therapeutical
agent for correcting surfactant deficiency in CDH.
This article has been cited by other articles:

|
 |

|
 |
 
O. Boucherat, A. Benachi, A.-M. Barlier-Mur, M.-L. Franco-Montoya, J. Martinovic, B. Thebaud, B. Chailley-Heu, and J. R. Bourbon
Decreased Lung Fibroblast Growth Factor 18 and Elastin in Human Congenital Diaphragmatic Hernia and Animal Models
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
1066 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Larson and J. C. Cohen
Improvement of pulmonary hypoplasia associated with congenital diaphragmatic hernia by in utero CFTR gene therapy
Am J Physiol Lung Cell Mol Physiol,
July 1, 2006;
291(1):
L4 - L10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Chapin, R. Ertsey, J. Yoshizawa, A. Hara, L. Sbragia, J. J. Greer, and J. A. Kitterman
Congenital diaphragmatic hernia, tracheal occlusion, thyroid transcription factor-1, and fetal pulmonary epithelial maturation
Am J Physiol Lung Cell Mol Physiol,
July 1, 2005;
289(1):
L44 - L52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Babiuk, B. Thebaud, and J. J. Greer
Reductions in the incidence of nitrofen-induced diaphragmatic hernia by vitamin A and retinoic acid
Am J Physiol Lung Cell Mol Physiol,
May 1, 2004;
286(5):
L970 - L973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Compliance (COMmunicate PLease wIth Less Abbreviations, Noun Clusters, and Exclusiveness)
Am. J. Respir. Crit. Care Med.,
December 15, 2002;
166(12):
1534 - 1536.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. TOBIN
Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2001
Am. J. Respir. Crit. Care Med.,
March 1, 2002;
165(5):
584 - 597.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. TOBIN
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001
Am. J. Respir. Crit. Care Med.,
March 1, 2002;
165(5):
619 - 630.
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 American Thoracic Society
|
|
|